• No results found

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis

N/A
N/A
Info
Download
Protected

Academic year: 2020

Share "A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis"

Copied!
28
0
0

Loading.... (view fulltext now)

Download now ( 28 Page )

Full text

Figure

Table 1. Survival rates: breast cancer, glioblastoma and cryptococcal meningitis.
Table 3. simple visual assessment.
Figure 1. Trial design and flow diagram.
Figure 2. Estimated power based on the two simulation studies.
+2

References

Download now ( PDF - 28 Page - 1.28 MB )

Related documents

Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial

Methods: A randomized, controlled, open-label, parallel group, multicentre, clinical trial was performed to evaluate the efficacy and safety of xyloglucan, in comparison

Laparoscopic versus open adhesiolysis for small bowel obstruction - a multicenter, prospective, randomized, controlled trial

Methods/Design: This is a multicenter, prospective, open label, randomized, controlled trial comparing laparoscopic adhesiolysis to open surgery in patients with

An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial

Methods: In an open label phase II trial, 122 patients were 1:1 randomized for SCIT using a grass pollen allergoid with an accelerated dose escalation comprising only 4

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE

Short Course High dose Liposomal Amphotericin B for HIV associated Cryptococcal Meningitis: A phase II Randomized Controlled Trial

? The Author(s) 2018 Published by Oxford University Press for the Infectious Diseases Society of America All rights reserved For permissions, e mail journals permissions@oup com

TRIBE-2: A phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

Methods/design: TRIBE-2 is a prospective, open-label, multicentric phase III randomized trial in which unresectable and previously untreated metastatic colorectal cancer patients

Effect of Vitamin E and Alpha Lipoic Acid in Nonalcoholic Fatty Liver Disease: A Randomized, Placebo Controlled, Open Label, Prospective Clinical Trial (VAIN Trial)

(2014) Effect of Vitamin E and Alpha Lipoic Acid in Nonalcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled, Open-Label, Prospective Clinical Trial (VAIN Trial).. This

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.

HERBY (HGG Efficacy and tolerability Research of Bevacizumab in Young children and adolescents; BO25041; clinicaltrials.gov NCT01390948) was a phase II, open-label,